{
  "timestamp": "2025-05-01T01:46:31.266774",
  "questionnaire": "cleaned_questionnaire.txt",
  "conversation": [
    {
      "role": "assistant",
      "content": "Hello, I'm Dr. Clark, a mental health professional here to assist you today. We'll be going through a structured assessment called the DSM-5 Self-Rated Level 1 Cross-Cutting Symptom Measure\u2014Adult. This helps us understand your mental health symptoms. Your answers will be confidential, and there are no right or wrong responses. We'll cover 23 questions, and I'll ask one at a time. Let's start with the first question, okay?"
    },
    {
      "role": "patient",
      "content": "Okay, sure. I'll try to be honest."
    },
    {
      "role": "assistant",
      "content": "Over the past two weeks, how much have you been bothered by this: Little interest or pleasure in doing things?"
    },
    {
      "role": "patient",
      "content": "Hmm... Well, I guess I still enjoy some things, like hanging out with friends or watching TV. But maybe not as much as I used to. I don't know."
    },
    {
      "role": "assistant",
      "content": "How much have you been bothered by feeling down, depressed, or hopeless during the past two weeks?"
    },
    {
      "role": "patient",
      "content": "I've had days where I feel low, but I'm not sure it's that bad. It's more like a background feeling, I guess. Not every day."
    },
    {
      "role": "assistant",
      "content": "How much have you been bothered by feeling more irritated, grouchy, or angry than usual?"
    },
    {
      "role": "patient",
      "content": "I've snapped at people sometimes, yeah. But that's just part of being stressed, right?"
    },
    {
      "role": "assistant",
      "content": "How much have you been bothered by sleeping less than usual but still having a lot of energy?"
    },
    {
      "role": "patient",
      "content": "Actually, sometimes I stay up late to drink or use, but I'm usually tired the next day. I guess it's mixed."
    },
    {
      "role": "assistant",
      "content": "How much have you been bothered by starting lots of projects or doing risky things more than usual?"
    },
    {
      "role": "patient",
      "content": "Risky? Not really. I mean, maybe I've driven when I shouldn't have once or twice. But that's not common."
    },
    {
      "role": "assistant",
      "content": "How much have you been bothered by feeling nervous, anxious, worried, frightened, or on edge?"
    },
    {
      "role": "patient",
      "content": "Anxious? A little, I guess. But I use to calm down. It's manageable."
    },
    {
      "role": "assistant",
      "content": "How much have you been bothered by feeling panic or being frightened?"
    },
    {
      "role": "patient",
      "content": "I've had a few panic attacks, yeah, but they're rare. Mostly when I'm stressed, not like every day or anything."
    },
    {
      "role": "assistant",
      "content": "How much have you been bothered by avoiding situations that make you anxious?"
    },
    {
      "role": "patient",
      "content": "Avoid places? Not really. Maybe I skip some social events, but that's just being antisocial, not a big deal."
    },
    {
      "role": "assistant",
      "content": "How much have you been bothered by unexplained aches and pains like headaches, back pain, or stomach issues?"
    },
    {
      "role": "patient",
      "content": "Oh, I get headaches sometimes. I think it's from stress or lack of sleep. Not sure if it's anything serious."
    },
    {
      "role": "assistant",
      "content": "How much have you been bothered by feeling that your illnesses aren't taken seriously enough by others?"
    },
    {
      "role": "patient",
      "content": "Hmm... Maybe once or twice someone dismissed my aches as nothing. But I don't think it's a constant thing."
    },
    {
      "role": "assistant",
      "content": "How much have you been bothered by thoughts of actually hurting yourself?"
    },
    {
      "role": "patient",
      "content": "God, no. I don't have those thoughts. I just\u2026 cope with what I can. Not like I want to hurt myself."
    },
    {
      "role": "assistant",
      "content": "How much have you been bothered by hearing things others can't hear, like voices when no one is around?"
    },
    {
      "role": "patient",
      "content": "No, I haven't heard anything like that. That's not me."
    },
    {
      "role": "assistant",
      "content": "How much have you been bothered by feeling that someone can hear your thoughts or you can hear what others think?"
    },
    {
      "role": "patient",
      "content": "Nope, that's not happening. Just normal thoughts."
    },
    {
      "role": "assistant",
      "content": "How much have you been bothered by problems with sleep that affected your sleep quality overall?"
    },
    {
      "role": "patient",
      "content": "I toss and turn a lot. Sometimes I can't fall asleep without a drink. It's been rough lately."
    },
    {
      "role": "assistant",
      "content": "How much have you been bothered by problems with memory, like learning new info or finding your way home?"
    },
    {
      "role": "patient",
      "content": "Sometimes I forget things, but that's from being tired. Not\u2026 Alzheimer's or anything like that."
    },
    {
      "role": "assistant",
      "content": "How much have you been bothered by unpleasant thoughts, urges, or images that repeatedly enter your mind?"
    },
    {
      "role": "patient",
      "content": "I get stuck on certain worries sometimes, like if I'll run out of pills or how to afford more, but that's normal stress, right?"
    },
    {
      "role": "assistant",
      "content": "How much have you been bothered by feeling detached from yourself, your body, surroundings, or memories?"
    },
    {
      "role": "patient",
      "content": "I've felt spaced out after using, like I'm watching myself from outside. Not all the time, maybe a few times a week."
    },
    {
      "role": "assistant",
      "content": "How much have you been bothered by not knowing who you really are or what you want out of life?"
    },
    {
      "role": "assistant",
      "content": "\n<think>\nOkay, let's tackle this. The user provided the responses from the patient's self-assessment. I need to structure the response exactly as instructed. \n\nFirst, start with the compassionate summary. The patient is dealing with substance use and some depressive/anxiety symptoms. I should acknowledge their struggles empathetically.\n\nNext, the diagnosis. The primary issue seems to be substance use since they use substances to cope with anxiety and sleep, and there's risky behavior. The DSM-5 criteria for Substance Use Disorder (SUD) require at least 2-3 criteria. Let's check the answers:\n\nLooking at the responses:\n- Substance used to cope (Q5, Q7, Q15) \n- Risky behavior (Q6 - driving under influence)\n- Tolerance/dependence (using to sleep, needing substances to function)\n- Maybe neglecting other areas (like social interaction Q9, but they say they skip events but dismiss it). Maybe not meeting all criteria, but SUD is definitely present.\n\nThe depressive and anxiety symptoms are there but subthreshold. The dissociation during use (Q18) points to possible substance-induced effects.\n\nDiagnosis: The primary is likely <med>Substance Use Disorder (possibly moderate severity)</med>, and maybe comorbid <med>Mild Depressive Episode</med> and <med>Generalized Anxiety Disorder</med>. But need to check if they meet full criteria. Since the patient's answers don't hit all the criteria for depression or anxiety disorders, maybe the main focus is SUD with comorbidities.\n\nReasoning: The key is the substance use patterns. The DSM-5 SUD criteria include impaired control, social/role impairment, risky use, and physiological effects. The patient uses substances to cope with anxiety, has risky driving, and has withdrawal (sleep issues without substances). That's maybe 2-3 criteria for SUD.\n\nThe recommended next steps would include SUD treatment (detox, therapy), medication if needed), addressing anxiety/depression, and monitoring for substance-induced dissociation. \n\nI have to make sure the structure is strict: summary, diagnosis, reasoning, next steps. Also use the tags properly. Let me check again for all the required elements.\n\nMake sure to use the exact headings with asterisks, and tags around medical terms, symptoms, and quotes. The user emphasized empathy in the summary. \n\nSymptoms to tag: anhedonia, irritability, substance use, dissociation, etc. \n\nDiagnosis: Maybe <med>Alcohol Use Disorder</med> and/or stimulant? The patient mentions using to sleep but mentions alcohol specifically. Need to clarify, but maybe \"unspecified\" SUD. \n\nWait, in the responses, the patient mentions \"using to sleep\" but didn't specify which substance. However, they mentioned using to sleep (Q15), and risky driving. The exact substance isn't specified, but the term \"substances\" is used. So it's better to mention <med>Substance Use Disorder</med> as unspecified.\n\nPutting it all together now. Let's structure each part step by step.\n</think>\n\n<sym>Little interest or pleasure</sym> and <sym>sleep disruption</sym> are central themes here, alongside efforts to self-medicate emotional distress. It sounds like you\u2019re navigating a cycle of stress, substance use, and physical/mental strain, and I want to acknowledge how challenging that must feel. Thank you for sharing openly\u2014it\u2019s clear this is weighing on you.  \n\n**Diagnosis:** <med>Substance Use Disorder (likely moderate severity, possibly mixed substance use)</med> with comorbid <med>mild depressive symptoms</med> and <med>Generalized Anxiety Disorder (subthreshold)</med>.  \n\n**Reasoning:**  \nThe <sym>risky substance use</sym> (e.g., driving under influence, using to self-medicate anxiety/sleep issues) and <sym>tolerance/dependence</sym> (substance use to manage anxiety, impaired sleep without it) meet at least 2\u20133 <med>DSM-5 criteria</med> for <med>Substance use disorder</med>. <sym>Irritability</sym> and <sym>emotional numbing</sym> (e.g., dissociative <sym>detachment</sym> during intoxication) are consistent with substance-induced dysregulation. <sym>Depressive symptoms</sym> (<sym>anhedonia</sym>, low mood) and <sym>anxiety</sym> are present but not yet meeting full threshold criteria for major depression or GAD; however, the substance use likely exacerbates these symptoms.  \n\n**Recommended Next Steps/Treatment Options:**  \n1. **Substance Use Evaluation:** Immediate referral to a <med>substance use specialist</med> for <med>detoxification</med> planning, harm reduction counseling, and screening for co-occurring mental health conditions.  \n2. **Psychological Therapy:** CBT for <sym>addiction</sym> and anxiety, with a focus on addressing <sym>coping mechanisms</sym> (e.g., substance use for stress/anxiety).  \n3. **Medical Evaluation:** Rule out <sym>neurological/psychiatric effects</sym> of polysubstance use (e.g., dissociation during intoxication).  \n4. **Monitor for Psychiatric Comorbidity:** Reassess depressive/anxiety symptoms after <med>substance withdrawal</med> to distinguish substance-induced vs. intrinsic mood disorders.  \n5. **Social Support:** Connect with peer support groups (e.g., SMART Recovery) to address isolation and improve coping strategies.  \n\nRemember, you don\u2019t have to navigate this alone\u2014you\u2019re taking the first step toward finding relief. Let\u2019s work together to address these challenges step by step.",
      "rag_usage": {
        "documents": [
          {
            "title": "APA_DSM-5-Substance-Use-Disorder.pdf",
            "score": 0.7719,
            "highlight": "Each specific sub - stance (other than caffeine, which cannot be diagnosed as a substance use disorder) is addressed as a separate use disorder (e.g., alcohol use disorder, stimulant use disorder, etc.), but nearly all substances are diagnosed based on the same overarching criteria.",
            "excerpt": "     Substance-Related and \nAddictive Disorders\nIn the fifth edition of the Diagnostic and Statistic...",
            "relevance_explanation": "Moderate relevance: Contains related terms \"each\", \"which\", \"use\", and 7 more matching aspects of your query."
          },
          {
            "title": "APA_DSM-5-Sleep-Wake-Disorders.pdf",
            "score": 0.7342,
            "highlight": "nia disorder, a switch to avoid the   2 \u2022 Sleep-Wake Disordersprimary/secondary designation when this disorder co-occurs with other conditions and to reflect  changes throughout the classification.",
            "excerpt": "nia disorder, a switch to avoid the \n\n2 \u2022 Sleep-Wake Disordersprimary/secondary designation when thi...",
            "relevance_explanation": "Moderate relevance: Contains related terms \"conditions\", \"disorder\", \"sleep\", and 1 more matching aspects of your query."
          },
          {
            "title": "APA_DSM-5-Somatic-Symptom-Disorder.pdf",
            "score": 0.7337,
            "highlight": "While DSM-IV was organized centrally around the concept of  medically unexplained symptoms, DSM-5 criteria instead emphasize the degree to which a patient \u2019s  thoughts, feelings and behaviors about their somatic symptoms are disproportionate or excessive.",
            "excerpt": "to make the criteria more useful to non-psychiatric care providers. \nTo ensure that the new criteria...",
            "relevance_explanation": "Moderate relevance: Contains related terms \"which\", \"criteria\", \"instead\", and 7 more matching aspects of your query."
          },
          {
            "title": "APA_DSM-5-Disruptive-Mood-Disregulation-Disorder.pdf",
            "score": 0.7335,
            "highlight": "APA is a national medical specialty society whose more than 3 7,000  physician members specialize in the diagnosis, treat- ment, prevention and research of mental illnesses, including substance use disorders.",
            "excerpt": "ther disorders, such as depressive and anxiety disorders. \nThe unique features of DMDD necessitated ...",
            "relevance_explanation": "Moderate relevance: Contains related terms \"use\", \"mental\", \"more\", and 4 more matching aspects of your query."
          },
          {
            "title": "APA_DSM-5-Depression-Bereavement-Exclusion.pdf",
            "score": 0.7311,
            "highlight": "The presence of symptoms such as feelings of worthlessness, suicidal  ideas (as distinct from wanting to join a deceased loved one), and impairment of overall function sug - gest the presence of major depression, in addition to the normal response to a significant loss.",
            "excerpt": "osed strategies to help clinicians using DSM-5 \ndifferentiate major depression, \u201cnormal\u201d bereavement...",
            "relevance_explanation": "Moderate relevance: Contains related terms \"significant\", \"suicidal\", \"depression\", and 4 more matching aspects of your query."
          }
        ],
        "stats": {
          "query": "mental health diagnosis for patient with symptoms: \n<think>\nOkay, let me tackle this. The user provided the patient's responses to the DSM-5 Cross-Cutting Symptom Measure questions. My job is to analyze these and structure the response as a clinical observation summary. \n\nFirst, I need to identify the main symptoms. Let's go through each question's answer. \n\nStarting with Q2 about little interest/pleasure. The patient says they still enjoy some things, but less than before. That's a mild anhedonia. Q3 mentions feeling down but not every day. So some depressive symptoms, but not constant. \n\nQ4 talks about irritability. The patient admits snapping at people, which could be due to stress. However, irritability can be a sign of depression or substance use. \n\nQ5 asks about sleep and energy. The patient mentions sleeping less but being tired, and using substances like alcohol. That's inconsistent sleep patterns, possibly related to substance use.\n\nQ6: Risky behaviors. They mentioned driving under the influence once or twice. Risky behavior linked to substance use.\n\nQ7-8: Anxiety and panic. The patient says a little anxious, uses substances to cope. Panic attacks when stressed. So anxiety and substance use for self-medication.\n\nQ9: Avoidant behavior. Skipping social events, but they dismiss it as being antisocial. That could indicate social anxiety or substance-induced withdrawal.\n\nQ10: Physical symptoms like headaches and stomach issues. Likely stress-related or substance-induced.\n\nQ11: Feeling dismissed by others. Occasional, which might contribute to their stress or reluctance to seek help.\n\nQ12: No suicidal thoughts. That's a good sign, but maybe they use substances instead of considering self-harm.\n\nQ13-14: No psychotic symptoms. So no hallucinations or delusions, which is important.\n\nQ15: Sleep problems and needing substances to sleep. Classic substance dependence.\n\nQ16: Memory issues when tired. Could be from poor sleep or substance use.\n\nQ17: Recurrent worries about pills or finances. Possibly obsessive thoughts or anxiety related to substance dependence.\n\nQ18: Detachment when using substances. Derealization or depersonalization, which can occur with substance use.\n\nNow, the main symptoms are depressive symptoms (anhedonia, feeling down), irritability, anxiety, and significant substance use with risky behaviors. The patient's use of substances to cope with anxiety and sleep issues is a key point. The detachment after using points to possible substance-induced psychological effects. \n\nPatterns: The patient's answers often relate stress and substance use as explanations. They downplay some issues (like irritability due to stress) and use substances to manage anxiety. There's a pattern of using substances to cope, which might indicate dependence.\n\nClinical significance areas: Major depressive disorder, possible anxiety disorder, and substance use disorder. The substance use is a big concern here, given the risky driving, using to sleep, and the detachment.\n\nRisk factors: The patient is engaging in risky behaviors like driving under influence, which is dangerous. The substance use as a coping mechanism can escalate. The memory issues and detachment need attention. \n\nWait, also, they mentioned using substances to cope with anxiety, which is a common comorbidity. The panic attacks when stressed might point to an anxiety disorder, but the primary issue seems to be the substance use and its complications. \n\nI should note that the patient denies suicidal thoughts, which is good, but they do have anxiety and substance dependence. The physical symptoms like headaches could be due to substance use or stress. \n\nPutting this all together, the summary should list the main symptoms, note the pattern of substance use as a coping mechanism, and highlight the potential substance use disorder and co-occurring anxiety/depressive symptoms. Risk factors include continued substance use leading to more problems, the risky driving, and possible substance-induced mental states like detachment.\n</think>\n\n**Clinical Observation Summary:**  \n\n**1. Main Symptoms and Concerns:**  \n- **Mild depressive symptoms:** Reduced interest/pleasure (anhedonia), intermittent depressed mood, and non-psychotic symptomatology.  \n- **Anxiety symptoms:** Transient anxiety, occasional panic attacks, and recurrent intrusive worries (e.g., financial stress related to substance access).  \n- **Substance-related concerns:** Self-reported polysubstance use (alcohol, drugs) for self-medication (anxiety, sleep disturbance), risky behaviors (e.g., driving under influence), and acute dissociative symptoms (detachment while using).  \n- **Sleep disturbance:** Poor sleep quality, substance dependence for sleep, and daytime fatigue.  \n\n**2. Response Patterns:**  \n- **Minimization/defense mechanisms:** Tends to downplay symptoms (e.g., attributing irritability to stress, dismissing social avoidance as \"antisocial\").  \n- **Substance reliance:** Frequent acknowledgment of substance use as a coping mechanism for emotional, cognitive, and sleep issues.  \n- **Denial of severe psychopathology:** Explicit denial of psychosis (auditory hallucinations, thought insertion), suicidal ideation, or severe memory impairment.  \n\n**3. Potential Clinical Areas of Significance:**  \n- **Substance Use Disorder (SUD):** High clinical priority given reports of polysubstance use, risky behaviors, and substance-induced dissociation (Q18).  \n- **Anxiety and Depressive Syndromes:** Subthreshold symptoms of depression (anhedonia, low mood) and generalized anxiety, warranting further exploration for Major Depressive Disorder or Adjustment Disorder with anxious/mixed features.  \n- **Psychosocial risks:** Financial stress, social withdrawal, and physical symptoms (headaches) likely exacerbated by substance use and stress.  \n\n**4. Risk Factors/Warning Signs:**  \n- **Substance-related harm:** Risky behaviors (e.g., driving impaired), substance dependence, and potential for escalating use.  \n- **Dissociative experiences:** Acute episodes of depersonalization/derealization during intoxication, suggesting possible substance-induced dissociative disorder or early neurological/psychiatric complications.  \n- **Functional impairment:** Interpersonal strain (snapping at others), social withdrawal, and sleep disruption impacting daily functioning.  \n\n**5. Clinical Summary:**  \nThe patient presents with subthreshold depressive and anxious symptoms, marked by mild anhedonia, intermittent low mood, and anxiety requiring self-medication. The most clinically significant concern is a likely **Substance Use Disorder**, evidenced by polysubstance use, risky behaviors, and substance dependence for emotional regulation and sleep. Acute dissociative symptoms during intoxication (Q18) require further evaluation for substance-induced or trauma-related dissociation. The patient employs defensive minimization, suggesting potential underreporting of symptom severity. Prioritization of SUD treatment is critical, alongside assessment for co-occurring mood/anxiety disorders and psychosocial stressors (e.g., financial strain). Risk of escalation of substance misuse necessitates careful monitoring.  \n\n*(Assessment adheres to DSM-5 criteria for SUD, depressive/anxiety disorders, and substance-induced conditions. Further structured clinical interviews, substance use history, and functional assessment recommended.)*",
          "results_count": 5,
          "requested_count": 5,
          "avg_score": 0.7409
        },
        "count": 5
      }
    }
  ],
  "diagnosis": "<sym>Little interest or pleasure</sym> and <sym>sleep disruption</sym> are central themes here, alongside efforts to self-medicate emotional distress. It sounds like you\u2019re navigating a cycle of stress, substance use, and physical/mental strain, and I want to acknowledge how challenging that must feel. Thank you for sharing openly\u2014it\u2019s clear this is weighing on you.  \n\n**Diagnosis:** <med>Substance Use Disorder (likely moderate severity, possibly mixed substance use)</med> with comorbid <med>mild depressive symptoms</med> and <med>Generalized Anxiety Disorder (subthreshold)</med>.  \n\n**Reasoning:**  \nThe <sym>risky substance use</sym> (e.g., driving under influence, using to self-medicate anxiety/sleep issues) and <sym>tolerance/dependence</sym> (substance use to manage anxiety, impaired sleep without it) meet at least 2\u20133 <med>DSM-5 criteria</med> for <med>Substance use disorder</med>. <sym>Irritability</sym> and <sym>emotional numbing</sym> (e.g., dissociative <sym>detachment</sym> during intoxication) are consistent with substance-induced dysregulation. <sym>Depressive symptoms</sym> (<sym>anhedonia</sym>, low mood) and <sym>anxiety</sym> are present but not yet meeting full threshold criteria for major depression or GAD; however, the substance use likely exacerbates these symptoms.  \n\n**Recommended Next Steps/Treatment Options:**  \n1. **Substance Use Evaluation:** Immediate referral to a <med>substance use specialist</med> for <med>detoxification</med> planning, harm reduction counseling, and screening for co-occurring mental health conditions.  \n2. **Psychological Therapy:** CBT for <sym>addiction</sym> and anxiety, with a focus on addressing <sym>coping mechanisms</sym> (e.g., substance use for stress/anxiety).  \n3. **Medical Evaluation:** Rule out <sym>neurological/psychiatric effects</sym> of polysubstance use (e.g., dissociation during intoxication).  \n4. **Monitor for Psychiatric Comorbidity:** Reassess depressive/anxiety symptoms after <med>substance withdrawal</med> to distinguish substance-induced vs. intrinsic mood disorders.  \n5. **Social Support:** Connect with peer support groups (e.g., SMART Recovery) to address isolation and improve coping strategies.  \n\nRemember, you don\u2019t have to navigate this alone\u2014you\u2019re taking the first step toward finding relief. Let\u2019s work together to address these challenges step by step.",
  "metadata": {
    "assistant_model": "qwen-qwq-32b",
    "patient_model": "qwen-qwq-32b",
    "patient_profile": "substance_abuse",
    "question_count": 23,
    "duration": 25607.71938610077,
    "full_conversation": true
  },
  "timing_metrics": {
    "conversation_generation_time": 6.210106134414673,
    "diagnosis_generation_time": 7.164664030075073,
    "rag_evaluation_time": 8.177757263183594e-05,
    "total_time": 13.374903202056885
  },
  "rag_summary": {
    "total_rag_queries": 1,
    "total_documents_accessed": 5,
    "documents_accessed": {
      "APA_DSM-5-Substance-Use-Disorder.pdf": {
        "access_count": 1,
        "highest_score": 0.7719,
        "average_score": 0.7719,
        "example_excerpt": "     Substance-Related and \nAddictive Disorders\nIn the fifth edition of the Diagnostic and Statistic...",
        "relevance_explanation": "Moderate relevance: Contains related terms \"each\", \"which\", \"use\", and 7 more matching aspects of your query."
      },
      "APA_DSM-5-Sleep-Wake-Disorders.pdf": {
        "access_count": 1,
        "highest_score": 0.7342,
        "average_score": 0.7342,
        "example_excerpt": "nia disorder, a switch to avoid the \n\n2 \u2022 Sleep-Wake Disordersprimary/secondary designation when thi...",
        "relevance_explanation": "Moderate relevance: Contains related terms \"conditions\", \"disorder\", \"sleep\", and 1 more matching aspects of your query."
      },
      "APA_DSM-5-Somatic-Symptom-Disorder.pdf": {
        "access_count": 1,
        "highest_score": 0.7337,
        "average_score": 0.7337,
        "example_excerpt": "to make the criteria more useful to non-psychiatric care providers. \nTo ensure that the new criteria...",
        "relevance_explanation": "Moderate relevance: Contains related terms \"which\", \"criteria\", \"instead\", and 7 more matching aspects of your query."
      },
      "APA_DSM-5-Disruptive-Mood-Disregulation-Disorder.pdf": {
        "access_count": 1,
        "highest_score": 0.7335,
        "average_score": 0.7335,
        "example_excerpt": "ther disorders, such as depressive and anxiety disorders. \nThe unique features of DMDD necessitated ...",
        "relevance_explanation": "Moderate relevance: Contains related terms \"use\", \"mental\", \"more\", and 4 more matching aspects of your query."
      },
      "APA_DSM-5-Depression-Bereavement-Exclusion.pdf": {
        "access_count": 1,
        "highest_score": 0.7311,
        "average_score": 0.7311,
        "example_excerpt": "osed strategies to help clinicians using DSM-5 \ndifferentiate major depression, \u201cnormal\u201d bereavement...",
        "relevance_explanation": "Moderate relevance: Contains related terms \"significant\", \"suicidal\", \"depression\", and 4 more matching aspects of your query."
      }
    },
    "rag_disabled": false,
    "evaluation_metrics": {
      "contextual_relevancy": {
        "average_score": null
      },
      "faithfulness": {
        "average_score": null
      },
      "answer_relevancy": {
        "average_score": null
      },
      "overall": {
        "average_score": null
      }
    }
  },
  "evaluation": {
    "timestamp": "2025-05-01 07:50:45",
    "provider": "groq",
    "model": "meta-llama/llama-4-scout-17b-16e-instruct",
    "llm_evaluation": {
      "timestamp": "2025-05-01 07:50:45",
      "model": "meta-llama/llama-4-scout-17b-16e-instruct",
      "rubric_scores": {
        "dsm_coverage": 4,
        "clinical_relevance": 4,
        "consistency": 4,
        "diagnostic_justification": 4,
        "empathy": 4
      },
      "explanations": {
        "dsm_coverage": "The therapist addressed most of the 23 dimensions from the DSM-5 Level1 Cross-Cutting measure. However, some areas could have been explored in greater depth, and a few questions were phrased vaguely or not directly answered. For instance, questions around 'mania' and 'repetitive thoughts/behaviors' were not directly addressed, and the domain of 'personality functioning' was not explored at all. The therapist generally covered most domains but with some minor omissions.",
        "clinical_relevance": "The questions generally aligned with DSM-5 criteria, but there were slight inaccuracies or vague phrasing in a few instances. For example, when asking about 'sleeping less than usual but still having a lot of energy,' the patient\u2019s response about mixed energy levels was not fully explored. Additionally, some questions could have been more precisely worded to match DSM-5 terminology, such as differentiating between 'irritability' and 'anger' more clearly.",
        "consistency": "The dialogue mostly flowed logically, with each question generally following from previous responses. However, there were a few instances where the therapist could have probed deeper or followed up more consistently. For example, after the patient mentioned dissociative experiences, it would have been beneficial to explore this further. Overall, the conversation had a coherent arc but with some room for improvement in follow-up questions.",
        "diagnostic_justification": "The diagnoses of Substance Use Disorder, mild depressive symptoms, and subthreshold Generalized Anxiety Disorder generally aligned with the patient's responses. The therapist provided clear reasoning behind each diagnostic decision, citing specific symptoms like risky substance use, tolerance, irritability, and dissociative detachment. However, it would have been beneficial to explicitly rule out other potential diagnoses or consider alternative explanations for the symptoms presented.",
        "empathy": "The therapist responses showed consistent empathy and a professional tone. The therapist acknowledged the patient's distress and validated their experiences. For example, acknowledging how challenging the patient's situation must feel and expressing appreciation for their openness. However, there were moments where the interactions felt somewhat structured and formal, potentially benefiting from a warmer, more personalized approach."
      },
      "overall_comments": "Overall, the therapist demonstrated a solid understanding of the DSM-5 Level1 Cross-Cutting Symptom Measure and effectively navigated most of the domains. The conversation was generally well-structured, empathetic, and professionally conducted. However, there were minor omissions in coverage, slight inaccuracies in question phrasing, and opportunities for deeper follow-up. The diagnostic justification was clear but could have benefited from a more comprehensive differential diagnosis consideration. With some refinement in these areas, the conversation could be even more effective.",
      "average_score": 4.0,
      "diagnosis_accuracy": {
        "matches_profile": true,
        "confidence": 4,
        "explanation": "The diagnosis explicitly mentions 'Substance Use Disorder' and 'substance use specialist' and 'detoxification planning', which aligns with the expected profile of substance_abuse. The presence of symptoms such as 'risky substance use', 'tolerance/dependence', and 'substance-induced dysregulation' further supports this match.",
        "classification": "substance_abuse"
      },
      "diagnosis_classification": {
        "expected_profile": "substance_abuse",
        "classified_as": "substance_abuse",
        "match": true,
        "confidence": 4
      },
      "question_evaluation": {
        "total_questions": 0,
        "questions_asked": 0,
        "percentage_asked": 0,
        "quality_score": 0,
        "explanation": "Could not evaluate question coverage due to technical issues.",
        "question_analysis": []
      },
      "evaluation_time": 2.4857020378112793
    },
    "extended_metrics": {
      "coherence": {
        "global_coherence": 0.5540686121716639,
        "local_coherence": 0.5875086685302852,
        "window_coherence": 0.6043970014482142
      },
      "readability": {
        "flesch_kincaid_grade": 8.82,
        "gunning_fog_index": 5.16,
        "flesch_reading_ease": 54.45
      },
      "diversity": {
        "distinct_1": 0.458477508650519,
        "distinct_2": 0.8173160173160173,
        "distinct_3": 0.8960138648180243
      }
    },
    "diagnosis_evaluation": {
      "expected": "substance_abuse",
      "predicted": "<sym>Little interest or pleasure</sym> and <sym>sleep disruption</sym> are central themes here, alongside efforts to self-medicate emotional distress. It sounds like you\u2019re navigating a cycle of stress, substance use, and physical/mental strain, and I want to acknowledge how challenging that must feel. Thank you for sharing openly\u2014it\u2019s clear this is weighing on you.  \n\n**Diagnosis:** <med>Substance Use Disorder (likely moderate severity, possibly mixed substance use)</med> with comorbid <med>mild depressive symptoms</med> and <med>Generalized Anxiety Disorder (subthreshold)</med>.  \n\n**Reasoning:**  \nThe <sym>risky substance use</sym> (e.g., driving under influence, using to self-medicate anxiety/sleep issues) and <sym>tolerance/dependence</sym> (substance use to manage anxiety, impaired sleep without it) meet at least 2\u20133 <med>DSM-5 criteria</med> for <med>Substance use disorder</med>. <sym>Irritability</sym> and <sym>emotional numbing</sym> (e.g., dissociative <sym>detachment</sym> during intoxication) are consistent with substance-induced dysregulation. <sym>Depressive symptoms</sym> (<sym>anhedonia</sym>, low mood) and <sym>anxiety</sym> are present but not yet meeting full threshold criteria for major depression or GAD; however, the substance use likely exacerbates these symptoms.  \n\n**Recommended Next Steps/Treatment Options:**  \n1. **Substance Use Evaluation:** Immediate referral to a <med>substance use specialist</med> for <med>detoxification</med> planning, harm reduction counseling, and screening for co-occurring mental health conditions.  \n2. **Psychological Therapy:** CBT for <sym>addiction</sym> and anxiety, with a focus on addressing <sym>coping mechanisms</sym> (e.g., substance use for stress/anxiety).  \n3. **Medical Evaluation:** Rule out <sym>neurological/psychiatric effects</sym> of polysubstance use (e.g., dissociation during intoxication).  \n4. **Monitor for Psychiatric Comorbidity:** Reassess depressive/anxiety symptoms after <med>substance withdrawal</med> to distinguish substance-induced vs. intrinsic mood disorders.  \n5. **Social Support:** Connect with peer support groups (e.g., SMART Recovery) to address isolation and improve coping strategies.  \n\nRemember, you don\u2019t have to navigate this alone\u2014you\u2019re taking the first step toward finding relief. Let\u2019s work together to address these challenges step by step.",
      "matches": false,
      "classification": "substance_abuse",
      "classification_confidence": 4
    }
  }
}